Urea/Ammonia Assay Kit (Rapid) (Bottle 1)

Hazard statements (CLP)

H315, H319, H360

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May damage fertility or the unborn child. Causes skin irritation. Causes serious eye irritation

Hazard pictograms

GHS07 GHS08 GHS07 GHS08

Signal word

Danger Danger

Contains

imidazole

Hazard statements

H315 - Causes skin irritation. H319 - Causes serious eye irritation. H360 - May damage fertility or the unborn child. H360 - May damage fertility or the unborn child.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P264 - Wash hands thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P302+P352 - IF ON SKIN: Wash with plenty of water. P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection.

Supplemental label elements

EUH032 - Contact with acids liberates very toxic gas. Labelling according to: exemption for packages of a capacity of 125ml or less EUH032 - Contact with acids liberates very toxic gas.

Hazardous Ingredients

imidazole

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Reproductive toxicity, Category 1B H360 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May damage fertility or the unborn child. Causes skin irritation. Causes serious eye irritation. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 GHS08 Signal word (CLP) : Danger Contains : imidazole Hazard statements (CLP) : H315 - Causes skin irritation. H319 - Causes serious eye irritation. H360 - May damage fertility or the unborn child. Precautionary statements (CLP) : P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P264 - Wash hands thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P302+P352 - IF ON SKIN: Wash with plenty of water. EUH-statements : EUH032 - Contact with acids liberates very toxic gas. Labelling according to: exemption for packages of a capacity of 125ml or less Hazard pictograms (CLP) : GHS07 GHS08 Signal word (CLP) : Danger Hazardous ingredients : imidazole Hazard statements (CLP) : H360 - May damage fertility or the unborn child. Precautionary statements (CLP) : P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. EUH-statements : EUH032 - Contact with acids liberates very toxic gas. 2.3. Other hazards Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Triethanolamine CAS-No.: 102-71-6 5 – 10 Not classified substance with national workplace exposure limit(s) EC-No.: 203-049-8 (IE) REACH-no: 01-2119486482- 31 imidazole CAS-No.: 288-32-4 1 – 5 Acute Tox. 4 (Oral), H302 EC-No.: 206-019-2 Skin Corr. 1C, H314 EC Index-No.: 613-319-00-0 Repr. 1B, H360D sodium azide CAS-No.: 26628-22-8 < 0,1 Acute Tox. 2 (Oral), H300 substance with a Community workplace exposure limit EC-No.: 247-852-1 Aquatic Acute 1, H400 EC Index-No.: 011-004-00-7 Aquatic Chronic 1, H410 Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures general : Never give anything by mouth to an unconscious person. IF exposed or concerned: Get medical advice/attention. First-aid measures after inhalation : Remove person to fresh air and keep comfortable for breathing. Allow affected person to breathe fresh air. Allow the victim to rest. Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTRE or doctor/physician. First-aid measures after skin contact : Immediately call a POISON CENTRE or doctor/physician. Wash skin with plenty of water. Take off contaminated clothing. If skin irritation occurs: Get medical advice/attention.